7 Research Compounds
All compounds HPLC-verified ≥98% purity — COA on every batch
Tirzepatide
A dual-action research compound investigated in laboratory models involving GIP and GLP-1 receptor pathway analysis, incretin signaling dynamics, and metabolic cascade characterization.
Starting at
$45.00
10-vial kit — save up to 25%
Semaglutide
A GLP-1 receptor analogue studied in research models involving incretin-related signaling pathway analysis, receptor binding dynamics, and metabolic pathway investigation.
Starting at
$55.00
10-vial kit — save up to 25%
Retatrutide
A triple-receptor research agonist studied in laboratory models involving GLP-1, GIP, and glucagon receptor pathway analysis and metabolic signaling characterization.
Starting at
$85.00
10-vial kit — save up to 25%
Cagrilintide
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Starting at
$65.00
10-vial kit — save up to 25%
cagrilintide 2.5mg+Semaglutide2.5mg
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Starting at
$40.00
cagrilintide 5mg+Semaglutide 5mg
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Starting at
$80.00
Survodutide
A research compound studied in laboratory models involving incretin-related signaling, metabolic pathway investigation, and compound characterization.
Starting at
$160.00
Research FAQs
Frequently Asked Questions
What are GLP-1 receptor agonist research peptides?
GLP-1 receptor agonist (GLP-1 RA) research peptides are synthetic compounds structurally related to native glucagon-like peptide-1 (GLP-1) that activate the GLP-1 receptor (GLP1R). They are used in preclinical research to study incretin receptor pharmacology, insulin secretion dynamics, energy balance, and metabolic signaling. AQRO Research supplies GLP-1 RA analogs including semaglutide, tirzepatide, retatrutide, and survodutide for laboratory research use only.
What is the difference between semaglutide and tirzepatide as research compounds?
Semaglutide is a selective GLP-1 receptor agonist analog with an extended half-life due to fatty acid conjugation, used in research as a reference GLP-1 RA. Tirzepatide is a dual GLP-1R/GIPR agonist that co-activates both the GLP-1 receptor and the GIP receptor, enabling researchers to study the additive or synergistic effects of dual incretin co-activation in metabolic models. Both are available from AQRO Research for laboratory research purposes only.
What research models are GLP-1 peptides used in?
GLP-1 research peptides are primarily used in diet-induced obesity (DIO) mouse models, ob/ob and db/db genetic models, oral glucose tolerance tests (OGTT), insulin tolerance tests (ITT), and in vitro receptor binding and cAMP signaling assays. They are not approved for human use.
All products are sold for laboratory research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Products are sold to qualified researchers and research institutions only.